WallStreetZenWallStreetZen

NASDAQ: SNDX
Syndax Pharmaceuticals Inc Stock Ownership - Who owns Syndax Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Syndax Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael A. MetzgerChief Executive Officer2025-03-146,074$7.20
$43.73kBuy
Michael A. MetzgerChief Executive Officer2025-03-047,814$7.20
$56.26kBuy
Michael A. MetzgerChief Executive Officer2025-03-047,814$15.05
$117.56kSell
Michael A. MetzgerChief Executive Officer2025-02-1013,288$15.50
$206.02kSell
Keith A. GoldanChief Financial Officer2025-02-103,777$15.50
$58.56kSell
Neil GallagherPresident Head of RD2025-02-104,618$15.50
$71.60kSell
Keith A. GoldanChief Financial Officer2024-06-141,250$20.03
$25.04kBuy

1 of 1

SNDX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SNDX insiders and whales buy or sell their stock.

SNDX Shareholders

What type of owners hold Syndax Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc10.50%9,033,949$121.24MInstitution
Kynam Capital Management LP9.90%8,520,000$114.34MInstitution
Goldman Sachs Group Inc6.92%5,950,537$79.86MInstitution
Morgan Stanley6.18%5,312,822$71.30MInstitution
Vanguard Group Inc5.68%4,881,968$65.52MInstitution
Wellington Management Group LLP4.92%4,234,455$56.83MInstitution
State Street Corp4.55%3,917,516$52.57MInstitution
Stempoint Capital LP3.34%2,872,601$38.55MInstitution
Soleus Capital Management LP2.90%2,492,000$33.44MInstitution
Avoro Capital Advisors LLC2.64%2,275,000$30.53MInstitution

1 of 3

SNDX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SNDX91.75%8.25%Net SellingNet Selling
IOVA18.22%81.78%Net SellingNet Selling
INVA58.96%41.04%Net SellingNet Selling
LQDA43.22%56.78%Net BuyingNet Selling
ADPT61.67%38.33%Net SellingNet Selling
View Top Biotech Stocks

Syndax Pharmaceuticals Stock Ownership FAQ

Who owns Syndax Pharmaceuticals?

Syndax Pharmaceuticals (NASDAQ: SNDX) is owned by 113.96% institutional shareholders, 10.25% Syndax Pharmaceuticals insiders, and 0.00% retail investors. Mpm Bioventures IV Qp LP is the largest individual Syndax Pharmaceuticals shareholder, owning 2.17M shares representing 2.52% of the company. Mpm Bioventures IV Qp LP's Syndax Pharmaceuticals shares are currently valued at $29.71M.

If you're new to stock investing, here's how to buy Syndax Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.